Atropine Sulfate NDC 24208-825

NDC codes

FDA NDC Directory

Product NDC (as listed)24208-825Labeler and product segments. Claims need a package NDC.

Product NDC at billing width24208-0825Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
24208-825-55	24208082555	1 TUBE in 1 CARTON (24208-825-55) / 3.5 g in 1 TUBEMarketed from Sep 30, 1990

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Atropine Sulfate
Generic name (nonproprietary): atropine sulfate
Active ingredients: Atropine sulfate — 10 mg/g
Dosage form: Ointment
Route: Ophthalmic
Labeler: Bausch & Lomb Incorporated
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Sep 30, 1990
Listing expires: Dec 31, 2026
Other FDA classes: Cholinergic Antagonists (Mechanism)Cholinergic Muscarinic Antagonists (Mechanism)
Identifiers: Product ID 24208-825_72b36d2b-77a4-4b9e-b99d-99bf20e45cc5SPL ID 72b36d2b-77a4-4b9e-b99d-99bf20e45cc5SPL set ID c0a56d60-0914-42b1-af59-c56afe93d18cRxCUI 1190570UNII 03J5ZE7KA5UPC 0324208825556
Pharmacologic class: Anticholinergic; Cholinergic Muscarinic Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N424208082555 followed by a unit qualifier and the quantity

Package 24208-0825-55. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 2, 2020.

Indications (excerpt from the label)

INDICATIONS AND USAGE For mydriasis and/or cycloplegia. For cycloplegic refraction, for pupillary dilation desired in inflammatory conditions of the iris and uveal tract.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)